Skip to main content

Table 3 Bi-variable and multivariable Cox- regression analysis for independent predictors of mortality among under-five children with SAM admitted in UOGCSH from 2014 to 2017, Gondar, Northwest Ethiopia(n = 527)

From: Predictors of mortality among under-five children with severe acute malnutrition, Northwest Ethiopia: an institution based retrospective cohort study

Variables

Event

Censored

CHR, 95% CI

AHR and 95% CI

p-value

Diarrhoea

 Yes

31

173

1.66 (0.8–2.69)

1.37 (0.79–2.4)

0.254

 No

35

288

1

1

 

Heart failure

 Yes

65

458

1.39 (0.63–3.06)

2.35 (0.91–6.02)

0.07

 No

58

427

1

1

 

Hiv/Aids

 Reactive

6

12

6.84 (0.43–19.2)

1.5 (0.45–4.97)

0.507

 Non-react

51

281

2.96 (0.46–6.02)

1.6 (0 .75–3.4)

0.215

 Unknown

9

168

1

1

 

Pneumonia

 Yes

9

65

0.93 (0.46–1.88)

1.1 (0.5–2.45)

0.8

 No

57

396

1

1

 

Folic acid

 Yes

36

346

1

1

0.525

 No

30

114

2.4 (1.48–3.9)

1.2 (0.67–2.16)

 

Anemia(< 11 mg/dl)

 Yes

49

221

2.57 (1.46–4.53)

2.37 (1.24–4.51)

0.023*

 No

16

226

1

1

 

Shock

 Yes

34

9

19.02 (11.65–31)

7.95 (3.72–16.7)

< 0.001*

 No

32

449

1

1

 

NGT feeding

 Yes

44

154

3.35 (2.0–5.61)

1.56 (0.7–2.04)

0.1

 No

22

307

1

1

 

Routine Antibiotics

 Yes

24

272

1

1

0.007*

 No

42

189

2.46 (1.49–4.07)

2.35 (1.25–4.4)

 

Iv fluid

 Yes

48

77

9.61 (5.58–16.5)

3.21 (1.75–5.88)

< 0.001*

 No

18

384

1

1

 

Blood transfusion

 Yes

27

31

6.36 (3.8–10.4)

1.9 (0.93–3.88)

0.077

 No

39

430

1

1

 

Intake of F75

 Yes

51

377

1

1

< 0.001*

 No

15

84

1.70 (0.95–3.04)

6.58 (2.9–14.68)

 

Intake F100

 Yes

24

315

1

1

< 0.001*

 No

42

146

5.27 (3.15–8.79)

3 (1.67–5.41)

 

Deworming

 Yes

5

54

1

1

0.45

 No

61

407

1.8 (0.9–9.2)

1.61 (0.46–5.64)

 

Pulse

 Normal

20

243

1

1

0.37

 Altered

46

211

2.34 (0.39–3.97)

2.39 (0.24–4.61)

 
  1. *Significant predictors in the multivariable analysis
  2. HIV/AIDS Human Immune-Virus /Acquired Immune Deficiency Syndrome
  3. NGT Naso Gastric Therapy